New therapeutic target for metabolic syndrome: PPARδ

S Takahashi, T Tanaka, J Sakai - Endocrine journal, 2007 - jstage.jst.go.jp
PEROXISOME proliferator-activated receptors (PPARs) are ligand-activated transcriptional
factors belonging to superfamily of nuclear hormone receptors related to retinoid, steroid …

[PDF][PDF] New Therapeutic Target for Metabolic Syndrome: PPARδ

S TAKAHASHI, T TANAKA, J SAKAI - Endocrine Journal, 2007 - scholar.archive.org
PEROXISOME proliferator-activated receptors (PPARs) are ligand-activated transcriptional
factors belonging to superfamily of nuclear hormone receptors related to retinoid, steroid …

[引用][C] New Therapeutic Target for Metabolic Syndrome: PPAR. DELTA.

T Sadao, T Toshiya, S Juro - Endocrine Journal, 2007 - cir.nii.ac.jp
New Therapeutic Target for Metabolic Syndrome: PPAR.DELTA. | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[引用][C] New therapeutic target for metabolic syndrome: PPARδ

S Takahashi, T Tanaka, J Sakai - Endocrine Journal, 2007 - tohoku.elsevierpure.com
New therapeutic target for metabolic syndrome: PPARδ — Tohoku University Skip to main
navigation Skip to search Skip to main content Tohoku University Home Tohoku University …

[引用][C] New therapeutic target for metabolic syndrome: PPARdelta.

S Takahashi, T Tanaka, J Sakai - Endocrine Journal, 2007 - europepmc.org
New therapeutic target for metabolic syndrome: PPARdelta. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

[引用][C] New therapeutic target for metabolic syndrome: PPARdelta

S Takahashi, T Tanaka, J Sakai - Endocrine journal, 2007 - pubmed.ncbi.nlm.nih.gov
New therapeutic target for metabolic syndrome: PPARdelta New therapeutic target for
metabolic syndrome: PPARdelta Endocr J. 2007 Jun;54(3):347-57. doi: 10.1507/endocrj.kr-99 …

[PDF][PDF] New Therapeutic Target for Metabolic Syndrome: PPARδ

S TAKAHASHI, T TANAKA, J SAKAI - researchgate.net
ARE ligand-activated transcriptional factors belonging to superfamily of nuclear hormone
receptors related to retinoid, steroid, and thyroid hormone receptors. Three subtypes …

New Therapeutic Target for Metabolic Syndrome: PPAR. DELTA.

S TAKAHASHI, T TANAKA, J SAKAI - Endocrine Journal, 2007 - jlc.jst.go.jp
PEROXISOME proliferator-activated receptors (PPARs) are ligand-activated transcriptional
factors belonging to superfamily of nuclear hormone receptors related to retinoid, steroid …

[引用][C] New Therapeutic Target for Metabolic Syndrome: PPARδ

S TAKAHASHI, T TANAKA, J SAKAI - Endocrine Journal, 2007 - jstage.jst.go.jp
ARE ligand-activated transcriptional factors belonging to superfamily of nuclear hormone
receptors related to retinoid, steroid, and thyroid hormone receptors. Three subtypes …

[PDF][PDF] New Therapeutic Target for Metabolic Syndrome: PPARδ

S TAKAHASHI, T TANAKA, J SAKAI - researchgate.net
ARE ligand-activated transcriptional factors belonging to superfamily of nuclear hormone
receptors related to retinoid, steroid, and thyroid hormone receptors. Three subtypes …